Product Discontinuation Notice

Dear Customer,

after careful consideration, QIAGEN has decided to discontinue the production of the aLF Reader with May 30, 2021 as final date of order placement and June 30, 2021 as final date of delivery. We will continue to provide lifecycle and service support until June 30, 2026.

While we regret any inconvenience this announcement may cause, we are pleased to supply you with alternate reader solutions for rapid testing from our subsidiary company DIALUNOX GmbH. Feel free to contact us for further questions.

Diagnostics-4-Future-Conference, Constance 2019

We would like to cordially invite you to the ‘Diagnostics-4-Future Conference’ that takes place on November 27-28, 2019 in Constance (Germany) and which is supported by QIAGEN Lake Constance as a Gold sponsor. The event adresses to companies, laboratories, clinics and research institutions and neighbouring areas like pharma, life science and medical technology. Leading experts from industry, medicine and research will join the event to discuss the “hot topics” in diagnostics:

• Cancer diagnostics
• Therapy monitoring
• Multiresistant pathogens
• Lifestyle & diagnostics
• Artificial Intelligence and digital diagnostics

Starting point are diagnostic questions of users (e.g. medical doctors, clinics, laboratories), which should give the impulse for new solutions by meeting with developers and technology suppliers. The event addresses also patient-oriented diagnostic solutions (point-of-care) to improve health care in rural areas. The conference will be accompanied by an exhibition and a poster award. For more information please click here.